ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,867Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 434

$1.53M Total Retail Price of All Prescriptions

Rank: 3 out of 434

1,140 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 1,140 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

28% of this provider’s 1,140 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 26,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 1,510 1,043 S3 1 4
OMEPRAZOLE 1,418 1,204 2 5
AMLODIPINE BESYLATE 1,217 1,049 3 6
LISINOPRIL 1,183 999 4 1
LEVOTHYROXINE SODIUM 1,074 895 5 3
LOVASTATIN 1,070 1,001 6 10
SIMVASTATIN 998 858 7 2
ALENDRONATE SODIUM 946 908 8 15
METOPROLOL TARTRATE 745 641 9 12
METFORMIN HCL 726 577 10 7
ATORVASTATIN CALCIUM 717 600 11 19
ZOLPIDEM TARTRATE 665 522 12 11
GABAPENTIN 603 488 13 14
LOSARTAN POTASSIUM 559 513 14 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 505 448 15 21
FUROSEMIDE 496 394 16 9
SPIRIVA 395 361 17 36
TAMSULOSIN HCL 343 307 18 29
ALLOPURINOL 340 287 19 25
CITALOPRAM HBR 326 258 20 23
POTASSIUM CHLORIDE 311 270 21 20
ATENOLOL 286 241 22 16
LOSARTAN-HYDROCHLOROTHIAZIDE 285 263 23 39
WARFARIN SODIUM 271 239 24 18
NABUMETONE 270 226 25 149
GEMFIBROZIL 251 227 26 62
GLIMEPIRIDE 244 189 27 58
ADVAIR DISKUS 237 192 28 52
TRIAMTERENE-HCTZ 228 223 29 47
FLUOXETINE HCL 228 163 29 32
ACTOS 222 208 31 85
DONEPEZIL HCL 219 214 32 35
HYDROCHLOROTHIAZIDE 217 180 33 8
TRAMADOL HCL 217 171 33 28
OXYCODONE HCL-ACETAMINOPHEN 211 117 S2 35 53
GLIPIZIDE ER 195 166 36 65
VENTOLIN HFA 188 155 37 30
CLONIDINE HCL 180 141 38 63
CIPROFLOXACIN HCL 170 140 39 55
METHADONE HCL 168 59 S2 40 108
LEVOXYL 167 125 41 130
TRAZODONE HCL 164 128 42 33
TRIAMCINOLONE ACETONIDE 163 140 43 94
POLYETHYLENE GLYCOL 3350 162 126 44 81
SPIRONOLACTONE 161 114 45 70
CARVEDILOL 159 140 46 24
MELOXICAM 159 133 46 46
FLUTICASONE PROPIONATE 158 135 48 26
CLOPIDOGREL 155 142 49 41
BENICAR HCT 154 152 50 155
FENOFIBRATE 151 113 51 43
METOPROLOL SUCCINATE 150 149 52 22
BENICAR 150 147 52 121
BENAZEPRIL HCL 138 119 54 49
CARISOPRODOL 138 67 R 54 44
OXYCODONE HCL 134 63 S2 56 34
TERAZOSIN HCL 127 118 57 40
DIGOXIN 124 118 58 69
ETODOLAC 122 90 59 137
MORPHINE SULFATE ER 121 27 S2 60 50
FINASTERIDE 120 104 61 54
EVISTA 119 113 62 132
PREDNISONE 115 96 63 42
PLAVIX 113 96 64 64
AMITRIPTYLINE HCL 112 107 R 65 57
ENALAPRIL MALEATE 108 82 66 59
PIOGLITAZONE HCL 107 98 R 67 186
SYMBICORT 101 100 68 93
TRICOR 101 83 68 141
DILTIAZEM ER 101 101 68 98
GLIPIZIDE 97 81 71 37
BENAZEPRIL-HYDROCHLOROTHIAZIDE 96 82 72 181
SERTRALINE HCL 96 79 72 27
CYCLOBENZAPRINE HCL 93 53 R 74 101
PANTOPRAZOLE SODIUM 92 79 75 66
AMOX TR-POTASSIUM CLAVULANATE 92 72 75 113
LEVOFLOXACIN 90 70 77 131
CLOTRIMAZOLE-BETAMETHASONE 84 73 78 124
ENDOCET 83 36 S2 79 158
OXYCODONE-ACETAMINOPHEN 82 62 S2 80 74
BUPROPION HCL SR 82 64 80 129
ROPINIROLE HCL 81 70 82 104
PAROXETINE HCL 81 64 82 61
MIRTAZAPINE 80 80 84 97
CRESTOR 80 64 84 84
TRIAMTERENE-HYDROCHLOROTHIAZID 79 79 86 191
RISPERIDONE 78 53 87 87
RAMIPRIL 77 71 88 136
KLOR-CON M20 77 73 88 142
SYNTHROID 76 75 90 67
IBUPROFEN 76 41 90 56
LIPITOR 76 67 90 133
ESTRADIOL 75 41 R 93 73
TESTOSTERONE CYPIONATE 73 59 S3 94 207
QVAR 73 66 94 90
ACETAMINOPHEN-CODEINE 72 58 S3 96 117
RANITIDINE HCL 70 29 97 31
LYRICA 70 34 97 140
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 45 97 96
PEN NEEDLE 69 59 100 83
NITROFURANTOIN 68 54 101 254
OXYBUTYNIN CHLORIDE 67 64 102 82
ESCITALOPRAM OXALATE 66 48 103 164
JANUVIA 66 57 103 115
PROAIR HFA 66 37 103 60
PROPRANOLOL HCL 65 49 106 102
MECLIZINE HCL 64 45 107 159
NOVOLOG FLEXPEN 61 42 108 138
FORADIL 60 41 109 215
AMLODIPINE BESYLATE-BENAZEPRIL 60 54 109 100
PREMARIN 59 36 R 111 187
TOPIRAMATE 57 14 112 221
DILTIAZEM 24HR CD 57 40 112 126
PRAVASTATIN SODIUM 56 56 114 17
ASMANEX 56 28 114 274
LEVEMIR FLEXPEN 55 51 116 139
LANTUS 55 32 116 80
LANTUS SOLOSTAR 54 41 118 71
BACLOFEN 53 28 119 77
CELEBREX 52 42 120 144
COMBIVENT 51 28 121 160
QUETIAPINE FUMARATE 51 38 121 128
AZITHROMYCIN 50 42 123 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.